Cases started on MDR-TB treatment in Latvia

Latvia: Cases started on MDR-TB treatment was 11 in 2024. ◆ Volatile

Latest (2024)
11
Change on year
down 42.1%
World rank
119th
of 193 countries
All-time high
398
in 2019
All-time low
10
in 2021
Years of data
14
2009–2024

Cases started on MDR-TB treatment in Latvia, 2009–2024

01002003004002009201620242009: 1242010: 872011: 1032012: 1102013: 792014: 702015: 632016: 392017: 382018: 412019: 3982021: 102022: 192024: 11

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for cases started on mdr-tb treatment in Latvia is 11, measured in 2024.

The figure is down 42.1% on the previous year and down 84.3% over ten years.

Over the whole period, cases started on mdr-tb treatment in Latvia peaked at 398 in 2019 and was at its lowest, 10, in 2021.

Latvia ranks 119th of 193 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Averages by decade

DecadeAverage LowestHighest Years
2000s 124 124 124 1
2010s 102.8 38 398 10
2020s 13.33 10 19 3

Countries ranked near Latvia

  1. 116 Switzerland 12 compare
  2. 116 Tunisia 12 compare
  3. 116 Eritrea 12 compare
  4. 119 Israel 11 compare
  5. 119 Paraguay 11 compare
  6. 122 Macao 10 compare

See the full ranking of 205 places →

More health data for Latvia

All data for Latvia →

Frequently asked questions

What is cases started on mdr-tb treatment in Latvia?
Cases started on mdr-tb treatment in Latvia was 11 in 2024, according to World Health Organization, Global Health Observatory.
What is the highest cases started on mdr-tb treatment recorded in Latvia?
The highest recorded value was 398 in 2019.
What is the lowest cases started on mdr-tb treatment recorded in Latvia?
The lowest recorded value was 10 in 2021.
How does Latvia rank for cases started on mdr-tb treatment?
Latvia ranks 119th out of 193 countries with data for 2024.
Is cases started on mdr-tb treatment rising or falling in Latvia?
Over the last ten years it is down 84.3%. The long-run trend across the full record is volatile.
Where does this Latvia data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Cases started on MDR-TB treatment. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 14 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

About this data

Indicator
Cases started on MDR-TB treatment
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
205 places, 3,209 data points, 2005–2024
Last refreshed